We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

World-First Device to Remove Bacterial Biofilm Inside Endoscopes

By HospiMedica International staff writers
Posted on 23 May 2024
Image: Khamsin is the only automated scope cleaner currently on the market that also eliminates human error (Photo courtesy of PFE Medical)
Image: Khamsin is the only automated scope cleaner currently on the market that also eliminates human error (Photo courtesy of PFE Medical)

Endoscopes, which are long, thin instruments equipped with a light and camera at one end, are essential for internal medical examinations. Despite advancements, cleaning these tools sufficiently remains a significant challenge. Due to the sensitivity of their materials and electronics, endoscopes cannot undergo standard sterilization procedures applied to other medical and laboratory equipment. They require meticulous, lengthy cleaning processes to avoid contamination. However, even with rigorous cleaning efforts, endoscopes can retain bacterial biofilms—dense clusters of bacteria that adhere to surfaces and each other, protected by a slimy layer. These biofilms exhibit increased resistance to both antibiotics and disinfectants, potentially leading to severe infections or even patient deaths despite thorough decontamination efforts. Now, a new device aims to improve the endoscope cleaning process and prevent contamination by automatically removing bacterial biofilm inside which can cause infections.

Aston University (Birmingham, UK) is collaborating with PFE Medical (Staffordshire, UK), a company specializing in medical products, to advance the cleaning of endoscopes. They are exploring whether fiber optic probes equipped with ultraviolet (UV) light can effectively detect biofilms inside endoscopes. This research could lead to the creation of a pioneering device that inspects endoscopes and ensures they are clear of biofilms before use, thereby enhancing patient safety. This initiative builds on a previous successful collaboration between Aston University and PFE Medical, which developed a device called Khamsin that significantly enhanced the endoscope cleaning process and is currently being tested in real-world settings. This new partnership will leverage PFE Medical’s expertise in endoscope functionality along with Aston University's Institute of Photonic Technologies (AIPT), renowned for its leading-edge research in photonics, medical lasers, and bio-sensing technology, to potentially transform endoscope safety and cleanliness in healthcare settings.

“Biofilm is a hidden killer, and we have no way to detect it currently without completely taking apart these medical devices,” said Rob Hartley, Managing Director of PFE Medical. “There is rising concern about microbial resistance and to find a way to objectively detect bacteria would be a true innovation that would have impact around the world.”

“It was exciting to go to PFE Medical recently and see Khamsin in action, knowing that this new product came from a project that only finished last year,” said Professor Kate Sugden, Deputy Dean of the School of Engineering & Applied Sciences who will lead the project. “It will be a challenge to match the success of the last project, but I am optimistic that we can draw on the combined talent and facilities once again to make a significant contribution to solving this problem.”

Related Links:
Aston University
PFE Medical 

Gold Member
12-Channel ECG
CM1200B
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
New
Electrically Operated Patient Lifter
SVL 205
New
Half Apron
Demi

Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: A research collaboration aims to further advance findings in human genomics research in cardiovascular diseases (Photo courtesy of 123RF)

Bayer and Broad Institute Extend Research Collaboration to Develop New Cardiovascular Therapies

A research collaboration will focus on the joint discovery of novel therapeutic approaches based on findings in human genomics research related to cardiovascular diseases. Bayer (Berlin, Germany) and... Read more